Key points are not available for this paper at this time.
This targeted microRNA delivery presents an effective and safe strategy as a stem cell and exosomal therapy in I/R cardiac repair.
Share your take
Add a clinician perspective alongside expert commentary.
Gao et al. (Sun,) studied this question.